Seven Hackensack Meridian Health Cancer Treatment Centers Now Offering Innovative Scalp Cooling Treatment to Prevent Hair Loss from Chemotherapy   

Seven Hackensack Meridian Health Cancer Treatment Centers Now Offering Innovative Scalp Cooling Treatment to Prevent Hair Loss from Chemotherapy

Seven Hackensack Meridian Health cancer treatment centers are now using the innovative Paxman Scalp Cooling System to prevent or reduce hair loss in patients who are receiving chemotherapy.

The Paxman Scalp Cooling System is used by 271 cancer treatment centers in the U.S. and 19 cancer centers in New Jersey, including Hackensack University Medical Center in Hackensack, NJ; Jersey Shore University Medical Center in Neptune, NJ; JFK Medical Center in Edison, NJ; Ocean Medical Center in Brick, NJ; Palisades Medical Center in North Bergen; Riverview Medical Center in Red Bank, NJ; and Southern Ocean Medical Center in Manahawkin, NJ.

Hair loss during chemotherapy — also called chemotherapy-induced alopecia — is a common side effect that can have a negative emotional and psychological impact, resulting in depression, stress, loss of self-esteem and loss of privacy. Fear of hair loss can also cause some patients to reject chemotherapy treatment.

“At Hackensack Meridian Health, our goal is to treat cancer while providing patients with the highest possible quality of life,” said Andre Goy, M.D., M.S., physician-in-chief of Oncology, Hackensack Meridian Health. “The Paxman Scalp Cooling System helps our patients look and feel more like themselves during cancer treatment, allowing them to maintain confidence, privacy, hope and a sense of control.”

Chemotherapy works by targeting all rapidly dividing cells in the body. Hair is the second-fastest dividing cell, so hair follicles are susceptible to damage from chemotherapy drugs that results in hair loss.

Scalp cooling is a simple treatment that has been proven to reduce the damage chemotherapy drugs cause to hair follicles. Lowering the temperature of the scalp before, during and after chemotherapy slows cell division in the hair and causes blood vessels in the scalp to narrow, reducing blood flow to the area around the hair follicles. As a result, smaller amounts of chemotherapy drugs are delivered to the hair follicles, which reduces hair loss.

Patients who choose to have scalp-cooling therapy wear the Paxman Scalp Cooling Cap for 30 minutes before chemotherapy infusion, during infusion, and for up to 90 minutes after infusion.

To learn more about the Paxman Scalp Cooling System, visit paxmanusa.com.

For additional information, please contact Katherine Emmanouilidis, Director, Communications & Public Relations, 551-996-3764.

We use cookies to improve your experience. Please read our Privacy Policy or click Accept.
X